1124 related articles for article (PubMed ID: 34502340)
1. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
2. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates.
Kavitha K; Sivakumar S; Ramesh B
Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567
[TBL] [Abstract][Full Text] [Related]
3. In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M
Ibrahim MAA; Abdelrahman AHM; Mohamed TA; Atia MAM; Al-Hammady MAM; Abdeljawaad KAA; Elkady EM; Moustafa MF; Alrumaihi F; Allemailem KS; El-Seedi HR; Paré PW; Efferth T; Hegazy MF
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916461
[TBL] [Abstract][Full Text] [Related]
4. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
Awoonor-Williams E; Abu-Saleh AAA
Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
[TBL] [Abstract][Full Text] [Related]
5. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein.
Moschovou K; Antoniou M; Chontzopoulou E; Papavasileiou KD; Melagraki G; Afantitis A; Mavromoustakos T
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958877
[TBL] [Abstract][Full Text] [Related]
7. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
Majumder R; Mandal M
J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
[TBL] [Abstract][Full Text] [Related]
8. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.
Shode FO; Idowu ASK; Uhomoibhi OJ; Sabiu S
J Biomol Struct Dyn; 2022 Sep; 40(14):6587-6602. PubMed ID: 33590806
[TBL] [Abstract][Full Text] [Related]
9.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
10. Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M
Mangiavacchi F; Botwina P; Menichetti E; Bagnoli L; Rosati O; Marini F; Fonseca SF; Abenante L; Alves D; Dabrowska A; Kula-Pacurar A; Ortega-Alarcon D; Jimenez-Alesanco A; Ceballos-Laita L; Vega S; Rizzuti B; Abian O; Lenardão EJ; Velazquez-Campoy A; Pyrc K; Sancineto L; Santi C
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208928
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.
Swain SS; Singh SR; Sahoo A; Hussain T; Pati S
J Biomol Struct Dyn; 2022 Sep; 40(14):6463-6476. PubMed ID: 33583350
[TBL] [Abstract][Full Text] [Related]
12. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
13. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study.
Ibrahim MAA; Mohamed EAR; Abdelrahman AHM; Allemailem KS; Moustafa MF; Shawky AM; Mahzari A; Hakami AR; Abdeljawaad KAA; Atia MAM
J Mol Graph Model; 2021 Jun; 105():107904. PubMed ID: 33798836
[TBL] [Abstract][Full Text] [Related]
14. Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
Cui J; Jia J
Eur J Med Chem; 2021 Dec; 225():113789. PubMed ID: 34438124
[TBL] [Abstract][Full Text] [Related]
15.
Ramadhan DSF; Siharis F; Abdurrahman S; Isrul M; Fakih TM
J Biomol Struct Dyn; 2022; 40(22):11526-11532. PubMed ID: 34338602
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel inhibitors of SARS-CoV-2 main protease (M
Verma S; Patel CN; Chandra M
J Comput Chem; 2021 Oct; 42(26):1861-1872. PubMed ID: 34287986
[TBL] [Abstract][Full Text] [Related]
17. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
18. Blue Biotechnology: Computational Screening of
Ibrahim MAA; Abdelrahman AHM; Atia MAM; Mohamed TA; Moustafa MF; Hakami AR; Khalifa SAM; Alhumaydhi FA; Alrumaihi F; Abidi SH; Allemailem KS; Efferth T; Soliman ME; Paré PW; El-Seedi HR; Hegazy MF
Mar Drugs; 2021 Jul; 19(7):. PubMed ID: 34356816
[TBL] [Abstract][Full Text] [Related]
19. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]